These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 30883928

  • 21. The Safety Profiles of Adalimumab, Infliximab, Etanercept, Secukinumab and Ustekinumab in Psoriasis - A 30-month Observational Cohort Prospective Study of Adverse Events in Biologic Therapy.
    Paluch Z, Marques E, Boháč P, Zemková K, Hercogová J.
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):7-16. PubMed ID: 38946182
    [Abstract] [Full Text] [Related]

  • 22. Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
    Feldman SR, Zhao Y, Navaratnam P, Friedman HS, Lu J, Tran MH.
    J Manag Care Spec Pharm; 2015 Mar; 21(3):201-9. PubMed ID: 25726029
    [Abstract] [Full Text] [Related]

  • 23. ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice.
    Vilarrasa E, Notario J, Bordas X, López-Ferrer A, Gich IJ, Puig L.
    J Am Acad Dermatol; 2016 Jun; 74(6):1066-72. PubMed ID: 27004803
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
    Echeverría-García B, Nuño-González A, Dauden E, Vanaclocha F, Torrado R, Belinchón I, Pérez-Zafrilla B, Grupo de estudio BIOBADADERM.
    Actas Dermosifiliogr; 2017 Mar; 108(2):168-170. PubMed ID: 27765165
    [No Abstract] [Full Text] [Related]

  • 26. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.
    Talamonti M, Galluzzo M, Bernardini N, Caldarola G, Persechino S, Cantoresi F, Egan CG, Potenza C, Peris K, Bianchi L.
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1737-1744. PubMed ID: 29776016
    [Abstract] [Full Text] [Related]

  • 27. Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry.
    van der Schoot LS, van den Reek JMPA, Groenewoud JMM, Otero ME, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Berends MAM, Arnold WP, Peters B, Andriessen MPM, Den Hengst CW, Kuijpers ALA, de Jong EMGJ.
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1913-1920. PubMed ID: 31177583
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K, Burden AD, Eaton JN, Hawkins NS.
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [Abstract] [Full Text] [Related]

  • 29. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real-life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists.
    Mahé E, Beauchet A, Hadj-Rabia S, Mazereeuw-Hautier J, Mallet S, Phan A, Severino-Freire M, Boralevi F, Aubert H, Barthélémy H, Girard C, Martin L, Piram M, Barbarot S, Balguerie X, Zitouni J, Phan C, Di Lernia V, Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie (SFD), Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), and Società Italiana di Dermatologia Pediatrica (S.I.Der.P.).
    Dermatol Ther; 2022 Nov; 35(11):e15828. PubMed ID: 36107157
    [Abstract] [Full Text] [Related]

  • 30. Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.
    Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O.
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2046-2054. PubMed ID: 28609574
    [Abstract] [Full Text] [Related]

  • 31. Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.
    Shahbaz A, Qiang J, Marinas JEC, Kim WB, Greaves S, Yeung J.
    Br J Dermatol; 2017 Jul; 177(1):297-298. PubMed ID: 27639251
    [No Abstract] [Full Text] [Related]

  • 32. Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria.
    Richter L, Vujic I, Sesti A, Monshi B, Sanlorenzo M, Posch C, Rappersberger K.
    J Dtsch Dermatol Ges; 2017 Mar; 15(3):309-317. PubMed ID: 28240404
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C, Plotnikova N, Au SC, Sorensen EP, Gottlieb A.
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [Abstract] [Full Text] [Related]

  • 36. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ, Hisaw LD, Worswick S.
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medication adherence among patients with psoriasis on traditional systemic and biologics treatment.
    Hambly R, Kelly A, Gilhooley E, Nic Dhonncha E, Murad A, Hughes R, Lally A, Kirby B.
    Br J Dermatol; 2018 Jan; 178(1):e46-e48. PubMed ID: 28762482
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.